The authors of the article "Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy" have corrected two figures in their manuscript. In Figure 2, the number of patients in the progressive disease (PD) group was incorrectly labeled as N=4 instead of N=5. In Figure S3, the labels for the solid and dashed lines were reversed, with the solid line labeled as "all median" and the dashed line labeled as "tumor median." Additionally, the legend for Figure S3 was updated to clarify that the all median and tumor median for the complete response (CR) and partial response (PR) group were the same, preventing the overlap of the dotted and solid lines in the CR/PR group. These corrections have been made online, and the authors apologize for any confusion caused by these errors.The authors of the article "Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy" have corrected two figures in their manuscript. In Figure 2, the number of patients in the progressive disease (PD) group was incorrectly labeled as N=4 instead of N=5. In Figure S3, the labels for the solid and dashed lines were reversed, with the solid line labeled as "all median" and the dashed line labeled as "tumor median." Additionally, the legend for Figure S3 was updated to clarify that the all median and tumor median for the complete response (CR) and partial response (PR) group were the same, preventing the overlap of the dotted and solid lines in the CR/PR group. These corrections have been made online, and the authors apologize for any confusion caused by these errors.